Women's Health
From the Journals
Variants of nine breast cancer genes associated with severe disease
Findings may potentially inform guidelines for gene panel testing. Breast cancer gene variants most often associated with triple-negative and/or...
Latest News
Poor trial representation tied to worse breast cancer survival
Patient groups such as patients of color, older patients, and those with comorbidities are not well represented in clinical trials, and it remains...
News from the FDA/CDC
Babies better protected from COVID if mother vaccinated during pregnancy: study
From the Journals
Women at higher risk of serious adverse events from cancer therapy
As cancer treatment becomes increasingly individualized, “sex may be an important consideration.”
From the Journals
Breast cancer now leading cause of cancer death in Black women
"Black women are 41% more likely to die from breast cancer than White women despite a lower risk of being diagnosed with the disease."
From the Journals
Endometriosis not linked with preterm birth, new study finds
Changing monitoring strategies to prevent preterm birth for women with the disease may not be necessary.
Latest News
Prophylactic meds may prevent cesarean bleeding
“As methylergonovine is a known contraindication to hypertensive and cardiovascular disorders, patients would have to be carefully screened.”
Latest News
Study questions reliability of maternal drug testing
“Cannabis and methadone were the significant factors leading to discordance with positive newborn meconium, which may reflect prior use earlier in...
Latest News
Updated endometriosis guidelines emphasize less laparoscopy, more hormone therapy
The first update in 7 years includes more than 100 best practice recommendations and highlights research gaps.
Latest News
Some U.S. women not getting ET for curable breast cancer
Half of breast cancer patients eligible for endocrine therapy are not receiving tamoxifen and aromatase inhibitors.
Latest News
Researchers eye cannabis for gynecologic pain
Counseling patients about cannabis products will remain a challenge until federal policies permit more research, doctors say.